Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue

MeSH terms

• Adenocarcinoma / secondary*
• Adenocarcinoma / therapy
• Adult
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antiemetics / therapeutic use
• Antineoplastic Agents / therapeutic use
• Antineoplastic Protocols
• Cisplatin / therapeutic use
• Combined Modality Therapy
• Docetaxel
• Epirubicin / therapeutic use
• Esophageal Achalasia / pathology*
• Esophageal Achalasia / therapy
• Esophageal Neoplasms / pathology*
• Esophageal Neoplasms / therapy
• Fatal Outcome
• Fluorouracil / therapeutic use
• Humans
• Intestinal Polyposis / congenital
• Intestinal Polyposis / pathology
• Intestinal Polyposis / therapy
• Liver Neoplasms / drug therapy
• Liver Neoplasms / secondary
• Male
• Neoplastic Syndromes, Hereditary
• Peritoneal Neoplasms / drug therapy
• Peritoneal Neoplasms / secondary
• Proton Pump Inhibitors / therapeutic use
• Taxoids / therapeutic use
• Trastuzumab